Clinical Trials Logo

Clinical Trial Summary

Probuphine (buprenorphine implant) is an investigational implant placed just below the skin containing buprenorphine (BPN). BPN is an approved treatment for opioid dependence. This is a 6-month, open-label, re-treatment study that will confirm the safety and efficacy of Probuphine in patients who have previously completed the 6-month PRO-806 study with either Probuphine, placebo or sublingual buprenorphine.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01262261
Study type Interventional
Source Titan Pharmaceuticals
Contact
Status Completed
Phase Phase 3
Start date November 2010
Completion date November 2011

See also
  Status Clinical Trial Phase
Terminated NCT00772785 - Study of Probuphine in Patients With Opioid Dependence Phase 3
Completed NCT00591617 - Optimizing Outcomes Using Suboxone for Opiate Dependence N/A
Completed NCT01075971 - Study of Two Formulations of Buprenorphine HCl in Opioid-dependent Subjects on Buprenorphine Maintenance Therapy (Study P04451) (COMPLETED) Phase 2
Completed NCT00913484 - Disulfiram for Cocaine Abuse in Buprenorphine Treatment Phase 2
Terminated NCT00269607 - Naltrexone Implants as Relapse Prevention Phase 2/Phase 3
Completed NCT00577005 - Efficacy of Levetiracetam in Cocaine-Abusing Methadone Maintained Patients Phase 2
Completed NCT01806389 - A Study of Breastfeeding in Buprenorphine Maintained Women N/A
Completed NCT00955162 - Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France ("RIME") Phase 4
Completed NCT00727675 - Chronic Pain and Opioid Dependence Assessment and Treatment N/A
Completed NCT00742170 - Transdermal Electroacupuncture for Opioid Detoxification Phase 1/Phase 2
Completed NCT01114308 - A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction Phase 3
Completed NCT00877591 - Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications Phase 1